JD-4000 series (Jenrin Discovery)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJD-4000 series (Jenrin Discovery)
Drug Alias Nameunspecified cytokine inhibitor program (Jenrin Discovery)JD-4000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokine receptors antagonists
TargetsCytokine receptors
Therapy Area/IndicationsInflammationPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJenrin Discovery Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJenrin Discovery Inc
Active IndicationsN/A
Inactive IndicationsInflammationPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A